Amyris, the U.S. industrial bioscience company led by John Melo, closed the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25 million investment from Koninklijke DSM N.V. (Royal DSM) with the remaining $25 million contributed by Vivo Capital.
Rome will be the Euro-mediterranean capital of the bioeconomy for a couple of days. The Italian Forum on Industrial Biotechnology and Bioeconomy (IFIB) goes to the Italian capital from 5 to 6 October at the Palazzo Rospigliosi, in front of the House of the President of the Republic.
The second edition of the Bioeconomy Investment Summit will take place on 14-15 December in Helsinki, Finland, organized by the European Commission and the European Forest Institute. Over 30 speakers from across the globe will share their views on how we can bring together the economy and the environment. “New advances in technology – the organizers say – mean that everything that can be made out of oil can be made from renewable, biological resources. There are huge environmental and business opportunities for a wide range of industries: construction, chemicals, textiles, energy, plastics”.
The bioeconomy is today, in our everyday life: Reverdia’s Biosuccinium® has been used in the production of biobased materials for VAUDE’s new Skarvan range. As part of the completely redesigned Summer 2018 Shoe Collection, they offer consumers a sustainable choice of trekking shoe with high-end design.
“Clusters can set an environment for investment and implementation. They can bring the right people together and help to identify both hurdles and how to overcome them, for example by scouting technologies or helping to find access to funding”. To say it – in this long and exclusive interview with Il Bioeconomista – is Tatjana Schwabe, scientific advisor at CLIB2021, the German cluster of industrial biotechnology based in Düsseldorf. With Schwabe with talk about the role of clusters in supporting the European bioeconomy.
Interview by Mario Bonaccorso
Avantium, the Dutch forerunner in renewable chemistry, locates a new pilot biorefinery at Chemie Park Delfzijl, in the Netherlands. Avantium and chemical giant AkzoNobel have signed a contract for the pilot plant accommodation and the supply of various facilities and services. The pilot plant will validate the technical and economic feasibility of Avantium’s Zambezi process, which aims to convert woodchips and other second generation biomass into raw materials for the chemical industry. This is an essential step in scaling up the technology from lab to commercial operations.
Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.
Arkema will invest some 300 million euros over five years in the biosourced polyamide 11 chain. This major investment will enable the French chemical group to increase by 50% its polyamide 11 global production capacities. The project falls in line with Arkema’s strategy to speed up its development in advanced materials, one of the key pillars of its future growth, sustained by a unique portfolio of innovations around the main sustainable development trends.
There is a new partnership in the world bioeconomy. Indian Oil Corporation Limited, India’s flagship national oil company and, LanzaTech, carbon recycling company based in Illinois, signed a Statement of Intent to construct the world’s first refinery off gas-to-bioethanol production facility in India.